Viatris Responds Regarding EpiPen Family of Auto-Injectors in Light of Spectrum Labs Epinephrine Recall


As we reported yesterday, Spectrum Laboratory Products issued a worldwide recall of certain lots of their powdered epinephrine used to manufacture finished dose products that treat a variety of life-threatening conditions including anaphylaxis.

Although some number of hospitals, clinics, and physicians’ offices will no doubt be affected, it is unknown whether epinephrine auto-injectors will be affected by the recall. We reached out to the manufacturers of auto-injectors marketed in the US — Viatris (formerly Mylan for EpiPen, EpiPen Jr), Kaleo (Auvi-Q), Amneal (Adrenaclick generic), Teva (EpiPen generic) and Adamis (Symjepi) — to find out.

Click to visit sponsor

The first to respond — Lauren C Kashtan, Head of Global Corporate, Portfolio and Operations Communications for Viatris — states the EpiPen family of auto-injectors is NOT affected by the recall:

Our thanks to Ms Kashtan for her prompt reply which will put the minds of many owners of EpiPens at ease.

Click here to see Kaleo’s response regarding Auvi-Q.

We will post the statements of the remaining manufacturers as we receive them.

Print or share this article
Click to visit sponsor
Dave Bloom
Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of

Find Allergy-Friendly Products